TY - JOUR
T1 - Cognitive changes during the menopausal transition
T2 - a longitudinal study in women with and without HIV
AU - Maki, Pauline M.
AU - Springer, Gayle
AU - Anastos, Kathryn
AU - Gustafson, Deborah R.
AU - Weber, Kathleen
AU - Vance, David
AU - Dykxhoorn, Derek
AU - Milam, Joel
AU - Adimora, Adaora A.
AU - Kassaye, Seble G.
AU - Waldrop, Drenna
AU - Rubin, Leah H.
N1 - Publisher Copyright:
Copyright © 2021 by The North American Menopause Society.
PY - 2021/1/11
Y1 - 2021/1/11
N2 - OBJECTIVE: To assess longitudinal changes in cognitive performance across menopause stages in a sample comprised primarily of low-income women of color, including women with HIV (WWH). METHODS: A total of 443 women (291 WWH; 69% African American; 18% Hispanic; median age = 42 y) from the Women's Interagency HIV Study completed tests of verbal learning and memory, attention/working memory, processing speed, verbal fluency, motor skills, and executive function first at an index premenopausal visit and thereafter once every 2 years for up to six visits (mean follow-up = 5.7 y). General linear-mixed effects regression models were run to estimate associations between menopause stages and cognition, in the overall sample and in WWH. We examined both continuous scores and categorical scores of cognitive impairment (yes/no >1 standard deviation below the mean). RESULTS: Adjusting for age and relevant covariates, the overall sample and WWH showed longitudinal declines in continuous measures of learning, memory, and attention/working memory domains from the premenopause to the early perimenopause and from the premenopause to the postmenopause, Ps < 0.05 to < 0.001. Effects on those same domains were also evident in categorical scores of cognitive impairment, with the increased odds of impairment ranging from 41% to 215%, Ps < 0.05 to < 0.001. The increase in predicted probability of impairment by menopausal stage (% affected) ranged from 4% to 13%. CONCLUSIONS: Menopause stage was a key determinant of cognition in a sample of low-income women of color, including WWH. Many of these changes reached a clinically significant level of cognitive impairment.
AB - OBJECTIVE: To assess longitudinal changes in cognitive performance across menopause stages in a sample comprised primarily of low-income women of color, including women with HIV (WWH). METHODS: A total of 443 women (291 WWH; 69% African American; 18% Hispanic; median age = 42 y) from the Women's Interagency HIV Study completed tests of verbal learning and memory, attention/working memory, processing speed, verbal fluency, motor skills, and executive function first at an index premenopausal visit and thereafter once every 2 years for up to six visits (mean follow-up = 5.7 y). General linear-mixed effects regression models were run to estimate associations between menopause stages and cognition, in the overall sample and in WWH. We examined both continuous scores and categorical scores of cognitive impairment (yes/no >1 standard deviation below the mean). RESULTS: Adjusting for age and relevant covariates, the overall sample and WWH showed longitudinal declines in continuous measures of learning, memory, and attention/working memory domains from the premenopause to the early perimenopause and from the premenopause to the postmenopause, Ps < 0.05 to < 0.001. Effects on those same domains were also evident in categorical scores of cognitive impairment, with the increased odds of impairment ranging from 41% to 215%, Ps < 0.05 to < 0.001. The increase in predicted probability of impairment by menopausal stage (% affected) ranged from 4% to 13%. CONCLUSIONS: Menopause stage was a key determinant of cognition in a sample of low-income women of color, including WWH. Many of these changes reached a clinically significant level of cognitive impairment.
UR - http://www.scopus.com/inward/record.url?scp=85103200924&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85103200924&partnerID=8YFLogxK
U2 - 10.1097/GME.0000000000001725
DO - 10.1097/GME.0000000000001725
M3 - Article
C2 - 33438895
AN - SCOPUS:85103200924
SN - 1072-3714
VL - 28
SP - 360
EP - 368
JO - Menopause
JF - Menopause
IS - 4
ER -